Related references
Note: Only part of the references are listed.Efficacy and tolerance of osilodrostat in patients with Cushing's syndrome due to adrenocortical carcinomas
Antoine Tabarin et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)
Progression of Vertebral Fractures in Patients with Adrenocortical Carcinoma Undergoing Mitotane Therapy
Deborah Cosentini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-Center Experience
Marilyne Daher et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Predictors of Mortality in Patients with Advanced Cancer-A Systematic Review and Meta-Analysis
Catherine Owusuaa et al.
CANCERS (2022)
The biochemical diagnosis of adrenal insufficiency with modern cortisol assays: Reappraisal in the setting of opioid exposure and hospitalization
Caitlin Colling et al.
CLINICAL ENDOCRINOLOGY (2022)
Simultaneous Care in Oncology: A 7-Year Experience at ESMO Designated Centre at Veneto Institute of Oncology, Italy
Antonella Brunello et al.
CANCERS (2022)
Quality of life impairment after a diagnosis of Cushing's syndrome
Susan M. Webb et al.
PITUITARY (2022)
Nutritional Factors during and after Cancer: Impacts on Survival and Quality of Life
Sebastien Salas et al.
NUTRIENTS (2022)
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation
Irene Tizianel et al.
CANCERS (2022)
Simultaneous care in oncology: Assessment of benefit in relation to symptoms, sex, and age in 753 patients
Antonella Galiano et al.
FRONTIERS IN ONCOLOGY (2022)
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen
Antonella Turla et al.
ENDOCRINE (2022)
Molecular genomic profiling of adrenocortical cancers in clinical practice
Sourat Darabi et al.
SURGERY (2021)
Pharmacological profile and effects of mitotane in adrenocortical carcinoma
Claudia Rita Corso et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
The Role of Nutritional Support for Cancer Patients in Palliative Care
Paolo Cotogni et al.
NUTRIENTS (2021)
Efficacy and safety of pharmacological cachexia interventions: systematic review and network meta-analysis
Manit Saeteaw et al.
BMJ SUPPORTIVE & PALLIATIVE CARE (2021)
Approach to the Patient Treated with Steroidogenesis Inhibitors
Frederic Castinetti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy
Salvatore Grisanti et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Personalizing Cancer Pain Therapy: Insights from the Rational Use of Analgesics (RUA) Group
Giustino Varrassi et al.
PAIN AND THERAPY (2021)
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question
Vittoria Basile et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
The Challenging Pharmacokinetics of Mitotane: An Old Drug in Need of New Packaging
Malik Salman Haider et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2021)
Management of adrenocortical carcinoma: are we making progress?
Barbara Kiesewetter et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)
Objective Response and Prolonged Disease Control of Advanced Adrenocortical Carcinoma with Cabozantinib
Matthias Kroiss et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Palliative Care and the Management of Common Distressing Symptoms in Advanced Cancer: Pain, Breathlessness, Nausea and Vomiting, and Fatigue
Lesley A. Henson et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
New perspectives for mitotane treatment of adrenocortical carcinoma
S. Puglisi et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia
Sara Peixoto da Silva et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma
Soraya Puglisi et al.
CANCERS (2020)
Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity
Kinga Salat
PHARMACOLOGICAL REPORTS (2020)
A case report of neurological adverse events caused by short-term and low-dose treatment of mitotane The role of therapeutic drug monitoring
Xin Liu et al.
MEDICINE (2020)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW ON THE EVALUATION AND MANAGEMENT OF ADRENOCORTICAL CARCINOMA IN AN ADULT: A PRACTICAL APPROACH
Katja Kiseljak-Vassiliades et al.
ENDOCRINE PRACTICE (2020)
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Fassnacht et al.
ANNALS OF ONCOLOGY (2020)
A case report of a TDM-guided optimization of mitotane for a safe and effective long-term treatment
Antonello Di Paolo et al.
JOURNAL OF CHEMOTHERAPY (2019)
Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial
Benedito A. Carneiro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival
Aoife M. Ryan et al.
NUTRITION (2019)
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
Mouhammed Amir Habra et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients
Deborah Cosentini et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Visualase - An alternative approach to both old and new problems in Neuro-Oncology Reply
Mario Caccese et al.
SEMINARS IN ONCOLOGY (2019)
High-Dose Mitotane-Induced Encephalopathy in the Treatment of Adrenocortical Carcinoma
Elise Pape et al.
ONCOLOGIST (2018)
Insulin resistance and body composition in cancer patients
R. Dev et al.
ANNALS OF ONCOLOGY (2018)
Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma
Felix Megerle et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Depression and anxiety in patients with cancer
Alexandra Pitman et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Depression and anxiety in patients with cancer
Alexandra Pitman et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer
Louise E. Daly et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
In-Hospital Palliative Care: Should We Need to Reconsider What Role Hospitals Should Have in Patients with End-Stage Disease or Advanced Cancer?
Paolo Cotogni et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Improving Patient and Caregiver Outcomes in Oncology: Team-Based, Timely, and Targeted Palliative Care
David Hui et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Should we avoid using ketoconazole in patients with severe Cushing's syndrome and increased levels of liver enzymes?
Marine Ollivier et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication
Juliane Lippert et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
ADVANCE CARE PLANNING AND END-OF-LIFE DECISION MAKING FOR PATIENTS WITH CANCER
Rajiv Agarwal et al.
SEMINARS IN ONCOLOGY NURSING (2018)
Integration of oncology and palliative care: a Lancet Oncology Commission
Stein Kaasa et al.
LANCET ONCOLOGY (2018)
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma
Melanie Claps et al.
ENDOCRINE (2018)
Metyrapone treatment in Cushing's syndrome: a real-life study
Filippo Ceccato et al.
ENDOCRINE (2018)
Utility of the NECPAL CCOMS-ICO© tool and the Surprise Question as screening tools for early palliative care and to predict mortality in patients with advanced chronic conditions: A cohort study
Xavier Gomez-Batiste et al.
PALLIATIVE MEDICINE (2017)
Implementing Evidence-Based Palliative Care Programs and Policy for Cancer Patients: Epidemiologic and Policy Implications of the 2016 American Society of Clinical Oncology Clinical Practice Guideline Update
Sarina R. Isenberg et al.
EPIDEMIOLOGIC REVIEWS (2017)
Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors
Judith E. K. Henning et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care)
Vittorina Zagonel et al.
TUMORI (2017)
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care)
Vittorina Zagonel et al.
TUMORI (2017)
European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma
S. Gaujoux et al.
BRITISH JOURNAL OF SURGERY (2017)
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism
Marco Russo et al.
CLINICAL ENDOCRINOLOGY (2016)
Integrating palliative care into the trajectory of cancer care
David Hui et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis
Marieke H. J. van den Beuken-van Everdingen et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2016)
Early Integration of Palliative Care in Oncology Practice: Results of the Italian Association of Medical Oncology (AIOM) Survey
Vittorina Zagonel et al.
JOURNAL OF CANCER (2016)
Palliative care in cancer: managing patients' expectations
Wsam A. Ghandourh
JOURNAL OF MEDICAL RADIATION SCIENCES (2016)
Cachexia and sarcopenia: mechanisms and potential targets for intervention
Josep M. Argiles et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Metabolic comorbidities in Cushing's syndrome
Francesco Ferrau et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients
Eleni Daniel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial
Marie A. Bakitas et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
Martin Fassnacht et al.
LANCET ONCOLOGY (2015)
Therapeutic strategies for Cushing's syndrome: an update
Filippo Ceccato et al.
EXPERT OPINION ON ORPHAN DRUGS (2015)
Global clinical response in Cushing's syndrome patients treated with mifepristone
Laurence Katznelson et al.
CLINICAL ENDOCRINOLOGY (2014)
Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer
Alfredo Berruti et al.
EUROPEAN UROLOGY (2014)
Quality of Cancer Pain Management: An Update of a Systematic Review of Undertreatment of Patients With Cancer
Maria Teresa Greco et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
Camilla Zimmermann et al.
LANCET (2014)
Delivering maximum clinical benefit at an affordable price: engaging stakeholders in cancer care
Ronan J. Kelly et al.
LANCET ONCOLOGY (2014)
Cancer-related fatigue-mechanisms, risk factors, and treatments
Julienne E. Bower
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
A comprehensive review of palliative care in patients with cancer
Reena Jaiswal et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2014)
The biology of depression in cancer and the relationship between depression and cancer progression
Jorge Luis Sotelo et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2014)
Adrenocortical carcinoma: A population-based study on incidence and survival in the Netherlands since 1993
Thomas M. A. Kerkhofs et al.
EUROPEAN JOURNAL OF CANCER (2013)
Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement
Vasileios Chortis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Comparison of Two Mitotane Starting Dose Regimens in Patients With Advanced Adrenocortical Carcinoma
T. M. Kerkhofs et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Cancer cachexia-pathophysiology and management
Hajime Suzuki et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Depression and Insomnia in Cancer: Prevalence, Risk Factors, and Effects on Cancer Outcomes
Michael R. Irwin
CURRENT PSYCHIATRY REPORTS (2013)
American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care
Thomas J. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology
Lowell E. Schnipper et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Martin Fassnacht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Quality of Care Management Decisions by Multidisciplinary Cancer Teams: A Systematic Review
Benjamin W. Lamb et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Mitotane, Metyrapone, and Ketoconazole Combination Therapy as an Alternative to Rescue Adrenalectomy for Severe ACTH-Dependent Cushing's Syndrome
Peter Kamenicky et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Components of Early Outpatient Palliative Care Consultation in Patients with Metastatic Nonsmall Cell Lung Cancer
Juliet Jacobsen et al.
JOURNAL OF PALLIATIVE MEDICINE (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Adrenocortical carcinoma: a clinician's update
Martin Fassnacht et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer
Jennifer S. Temel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Merits and pitfalls of mifepristone in Cushing's syndrome
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Classification of pain in cancer patients - a systematic literature review
A. K. Knudsen et al.
PALLIATIVE MEDICINE (2009)
Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment
Kristine A. Donovan et al.
HEALTH PSYCHOLOGY (2007)
Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site
Adedayo A. Onitilo et al.
GENERAL HOSPITAL PSYCHIATRY (2006)
Extent of disease at presentation and outcome for adrenocortical carcinoma: Have we made progress?
E Kebebew et al.
WORLD JOURNAL OF SURGERY (2006)
Clinical review: Adrenocortical carcinoma: Clinical update
Bruno Allolio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease
JP Solano et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2006)
Beyond advance directives. Importance of communication skills at the end of life
JA Tulsky
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Simultaneous care: A model approach to the perceived conflict between investigational therapy and palliative care
FJ Meyers et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2004)
Palliative care:: The world health organization's global perspective
C Sepúlveda et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
Amitriptyline v. the rest:: still the leading antidepressant after 40 years of randomised controlled trials
C Barbui et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines
IM Anderson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2000)
Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life
JE Bower et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
